Technical Analysis for CRSP - CRISPR Therapeutics AG
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Outside Day | Range Expansion | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Inside Day | Range Contraction | -2.06% | |
Multiple of Ten Bearish | Other | -3.58% | |
Gapped Up | Strength | -3.58% | |
Upper Bollinger Band Touch | Strength | -3.58% | |
Crossed Above 20 DMA | Bullish | -0.04% | |
Crossed Above 50 DMA | Bullish | -0.04% | |
180 Bullish Setup | Bullish Swing Setup | -0.04% | |
Fell Below 20 DMA | Bearish | 4.20% |
Alert | Time |
---|---|
Down 2 % | about 14 hours ago |
Fell Below 10 DMA | about 15 hours ago |
60 Minute Opening Range Breakdown | about 15 hours ago |
Rose Above Previous Day's High | about 17 hours ago |
Outside Day | about 17 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/04/2024
Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine CRISPR DNA Genome Editing Cas9
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 91.1 |
52 Week Low | 43.42 |
Average Volume | 1,009,452 |
200-Day Moving Average | 58.31 |
50-Day Moving Average | 47.18 |
20-Day Moving Average | 47.26 |
10-Day Moving Average | 48.17 |
Average True Range | 1.67 |
RSI (14) | 51.22 |
ADX | 15.93 |
+DI | 20.05 |
-DI | 18.89 |
Chandelier Exit (Long, 3 ATRs) | 45.49 |
Chandelier Exit (Short, 3 ATRs) | 49.45 |
Upper Bollinger Bands | 50.25 |
Lower Bollinger Band | 44.26 |
Percent B (%b) | 0.61 |
BandWidth | 12.69 |
MACD Line | 0.35 |
MACD Signal Line | 0.19 |
MACD Histogram | 0.1574 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 51.34 | ||||
Resistance 3 (R3) | 51.61 | 50.74 | 50.77 | ||
Resistance 2 (R2) | 50.74 | 49.87 | 50.60 | 50.58 | |
Resistance 1 (R1) | 49.33 | 49.33 | 48.90 | 49.07 | 50.39 |
Pivot Point | 48.47 | 48.47 | 48.25 | 48.33 | 48.47 |
Support 1 (S1) | 47.06 | 47.60 | 46.63 | 46.79 | 45.47 |
Support 2 (S2) | 46.20 | 47.06 | 46.06 | 45.28 | |
Support 3 (S3) | 44.79 | 46.20 | 45.09 | ||
Support 4 (S4) | 44.52 |